Sự biến đổi trong siêu âm qua sọ ở bệnh nhân Huntington có triệu chứng tâm thần

Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the Beck Depression Inventory twenty-five years of evaluation. Clin Psychol Rev 8:77–100. https://doi.org/10.1016/0272-7358(88)90050-5

Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckmann H, Reiners K (1997) Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63(5):590–596. https://doi.org/10.1136/jnnp.63.5.590

Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76(3):423–425. https://doi.org/10.1136/jnnp.2004.049221

Berg D, Siefker C, Becker G (2001) Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248(8):684–689. https://doi.org/10.1007/s004150170114

Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59(6):999–1005. https://doi.org/10.1001/archneur.59.6.999

Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington's disease. J Med Genet 30(4):293–295. https://doi.org/10.1136/jmg.30.4.293

Du X, Pang T, Hannan AJ (2013) A tale of two maladies? Pathogenesis of depression with and without the Huntington’s disease gene mutation. Front Neurol 4:81. https://doi.org/10.3389/fneur.2013.00081

Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC (2007) Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 62(12):1341–1346. https://doi.org/10.1016/j.biopsych.2006.11.034

Handley O, van Walsem M, Juni P et al (2011) Study Protocol of Registry—version 2.0—European Huntington’s Disease Network. Hygeia Public Health 46(2):115–182

Jurgens CK, Jasinschi R, Ekin A, Witjes-Ané MN, Middelkoop H, van der Grond J, Roos RA (2010) MRI T2 hypointensities in basal ganglia of premanifest Huntington's disease. PLoS Curr 8:2. https://doi.org/10.1371/currents.RRN1173

Kostić M, Munjiza A, Pesic D, Peljto A, Novakovic I, Dobricic V, Tosevski DL, Mijajlovic M (2017) A pilot study on predictors of brainstem raphe abnormality in patients with major depressive disorder. J Affect Disord 209:66–70. https://doi.org/10.1016/j.jad.2016.11.034

Krogias C, Walter U (2016) Transcranial sonography findings in depression in association with psychiatric and neurologic diseases: a review. J Neuroimaging 26(3):257–263. https://doi.org/10.1111/jon.12328

Krogias C, Eyding J, Postert T (2010) Transcranial sonography in Huntington's disease. Int Rev Neurobiol 90:237–257. https://doi.org/10.1016/S0074-7742(10)90017-2

Krogias C, Strassburger K, Eyding J, Gold R, Norra C, Juckel G, Saft C, Ninphius D (2011) Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography. J Psychiatry Neurosci 36(3):187–194. https://doi.org/10.1503/jpn.100067

Mijajlovic M (2012) Transcranial sonography in psychiatric diseases. Perspect Med 1–12:357–361. https://doi.org/10.1016/j.permed.2012.02.039

Muller M, Leavitt BR (2014) Iron dysregulation in Huntington's disease. J Neurochem 130(3):328–350. https://doi.org/10.1111/jnc.12739

Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, Van Kammen DP (2010) Challenges assessing clinical endpoints in early Huntington disease. Mov Disord 25(15):2595–2603. https://doi.org/10.1002/mds.23337

Postert T, Lack B, Kuhn W, Jergas M, Andrich J, Braun B, Przuntek H, Sprengelmeyer R, Agelink M, Büttner T (1999) Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 67(4):457–462. https://doi.org/10.1136/jnnp.67.4.457

Prestel J, Schweitzer KJ, Hofer A, Gasser T, Berg D (2006) Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Movement Disord 21(10):1763–1765. https://doi.org/10.1002/mds.21054

Richter D, Woitalla D, Muhlack S, Gold R, Tönges L, Krogias C (2018) Brainstem raphe alterations in TCS: a biomarker for depression and apathy in Parkinson's disease patients. Front Neurol 7(9):645. https://doi.org/10.3389/fneur.2018.00645

Richter D, Katsanos AH, Schroeder C, Tsivgoulis G, Paraskevas GP, Muller T, Alexandrov AV, Gold R, Tonges L, Krogias C (2020) Lentiform nucleus hyperechogenicity in parkinsonian syndromes: a systematic review and meta-analysis with consideration of molecular pathology. Cells 9:2. https://doi.org/10.3390/cells9010002

Saft C, Hoffmann R, Strassburger-Krogias K, Lücke T, Meves SH, Ellrichmann G, Krogias C (2015) Echogenicity of basal ganglia structures in different Huntington's disease phenotypes. J Neural Transm (Vienna) 122(6):825–833. https://doi.org/10.1007/s00702-014-1335-7

Schminke U, Lorenz L, Kirsch M, von Sarnowski B, Khaw AV, Kessler C, Dressel A (2010) Diameter assessment of the third ventricle with transcranial sonography in patients with multiple sclerosis. J Neuroimaging 20(1):53–57. https://doi.org/10.1111/j.1552-6569.2008.00321.x

Svetel M, Mijajlović M, Tomić A, Kresojević N, Pekmezović T, Kostić VS (2012) Transcranial sonography in Wilson's disease. Parkinsonism Relat Disord 18(3):234–238. https://doi.org/10.1016/j.parkreldis.2011.10.007

Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637–649. https://doi.org/10.1016/S1474-4422(13)70088-7

Van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, van der Mast RC (2008) Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 69(11):1804–1810. https://doi.org/10.4088/jcp.v69n1116

Walter U (2009) Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy. Expert Rev Neurother 9(6):835–846. https://doi.org/10.1586/ern.09.41

Walter U, Skoloudik D (2014) Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med 35:322–331. https://doi.org/10.1055/s-0033-1356415

Walter U, Dressler D, Probst T, Wolters A, Abu-Mugheisib M, Wittstock M, Benecke R (2007) Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 64(11):1635–1640. https://doi.org/10.1001/archneur.64.11.1635

Wollenweber FA, Schomburg R, Probst M, Schneider V, Hiry T, Ochsenfeld A, Mueller M, Dillmann U, Fassbender K, Behnke S (2011) Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time- and cost-effective manner–results from a longitudinal study on 500 subjects. Psychiatry Res 191(3):212–216. https://doi.org/10.1016/j.pscychresns.2010.09.010